Novel lysin Abp013 has shown promising antimicrobial ability against Acinetobacter baumannii and Klebsiella pneumoniae. Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, alongside collaborators at Nanyang Technological University, have identified a novel phage lysin — Abp013 — that could be used as an alternative antimicrobial...